[go: up one dir, main page]

UY31582A1 - Derivado de 17- ( 1' - propenil) - 17-3' - oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen - Google Patents

Derivado de 17- ( 1' - propenil) - 17-3' - oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen

Info

Publication number
UY31582A1
UY31582A1 UY31582A UY31582A UY31582A1 UY 31582 A1 UY31582 A1 UY 31582A1 UY 31582 A UY31582 A UY 31582A UY 31582 A UY31582 A UY 31582A UY 31582 A1 UY31582 A1 UY 31582A1
Authority
UY
Uruguay
Prior art keywords
oxidoestra
propenil
ona
derived
derivatives
Prior art date
Application number
UY31582A
Other languages
English (en)
Inventor
Thomas Frenzel
Frederik Menges
Jan Huebner
Hans-Peter Muhn
Steffen Borden
Katja Prelle
Sven Ring
Rolf Bohlmann
Ulrich Klar
Joachin Kuhnke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40679349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31582(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of UY31582A1 publication Critical patent/UY31582A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/007—3 membered carbocyclic rings in position 6-7

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Derivados de 17-(1' -propenil) -17-3' -oxidoestra-4eb3ona que tienen la formula química general I , en la cual Z, R4, R6a, R6b, R7, R15, R16a, R16b y R18 tienen los valores que se indican en la reivindicacion 1, así como sus solvatos e hidratos y sales incluyendo tdos los estereoisomeros de estos compuestos. Uso de estos derivados para la preparacion de un medicamento para contracepcion oral y para el tratamiento de los trastornos pre , pri y posmenopáusicos y a medicamentos que contienen tales derivados particularmente en las indicaciones mencionadas.
UY31582A 2007-12-29 2008-12-26 Derivado de 17- ( 1' - propenil) - 17-3' - oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen UY31582A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007063500A DE102007063500A1 (de) 2007-12-29 2007-12-29 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
UY31582A1 true UY31582A1 (es) 2009-08-03

Family

ID=40679349

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31582A UY31582A1 (es) 2007-12-29 2008-12-26 Derivado de 17- ( 1' - propenil) - 17-3' - oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen

Country Status (23)

Country Link
US (1) US9034856B2 (es)
EP (1) EP2238147B1 (es)
JP (1) JP5600069B2 (es)
KR (1) KR20100102190A (es)
CN (1) CN101918426A (es)
AR (1) AR069964A1 (es)
AU (1) AU2008342912A1 (es)
BR (1) BRPI0822068A2 (es)
CA (1) CA2710934C (es)
CL (1) CL2008003885A1 (es)
CR (1) CR11541A (es)
DE (1) DE102007063500A1 (es)
DO (1) DOP2010000201A (es)
EC (1) ECSP10010316A (es)
ES (1) ES2397985T3 (es)
IL (1) IL206381A0 (es)
MX (1) MX2010007269A (es)
PA (1) PA8807901A1 (es)
PE (1) PE20091185A1 (es)
TW (1) TW200940562A (es)
UY (1) UY31582A1 (es)
WO (1) WO2009083268A2 (es)
ZA (1) ZA201005397B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012059594A1 (en) 2010-11-04 2012-05-10 Bayer Pharma Aktiengesellschaft Mineralcorticoid receptor antagonists for the treatment of corticoid-induced obesity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1183500B (de) 1962-10-12 1964-12-17 Schering Ag Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe
CH559220A5 (es) 1970-03-06 1975-02-28 Ciba Geigy Ag
US3705179A (en) 1971-03-15 1972-12-05 American Home Prod Antiandrogenic steroids
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
NL7701384A (nl) 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
DE2922500A1 (de) 1979-05-31 1980-12-04 Schering Ag 6 beta .7 beta
DE3402329A1 (de) 1984-01-20 1985-08-01 Schering AG, 1000 Berlin und 4709 Bergkamen 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2598421B1 (fr) 1986-05-06 1988-08-19 Roussel Uclaf Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4232521A1 (de) 1992-09-22 1994-03-24 Schering Ag Gestagen wirksame 4,5;11,12-Estradiene, Verfahren zu ihrer Herstellung, diese Estradiene enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
DE19651000A1 (de) 1996-12-01 1998-06-04 Schering Ag Oxyiminopregnancarbolactone
DE102004063864A1 (de) 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate

Also Published As

Publication number Publication date
DOP2010000201A (es) 2010-07-15
BRPI0822068A2 (pt) 2015-06-23
AU2008342912A1 (en) 2009-07-09
ES2397985T3 (es) 2013-03-12
ZA201005397B (en) 2012-01-25
DE102007063500A1 (de) 2009-07-02
PA8807901A1 (es) 2009-07-23
AR069964A1 (es) 2010-03-03
EP2238147B1 (de) 2012-10-24
KR20100102190A (ko) 2010-09-20
US20100317632A1 (en) 2010-12-16
CN101918426A (zh) 2010-12-15
TW200940562A (en) 2009-10-01
IL206381A0 (en) 2010-12-30
EP2238147A2 (de) 2010-10-13
WO2009083268A2 (de) 2009-07-09
PE20091185A1 (es) 2009-09-06
CL2008003885A1 (es) 2010-05-07
WO2009083268A3 (de) 2009-09-24
MX2010007269A (es) 2010-10-15
CA2710934C (en) 2015-07-21
US9034856B2 (en) 2015-05-19
ECSP10010316A (es) 2010-08-31
JP5600069B2 (ja) 2014-10-01
JP2011507925A (ja) 2011-03-10
CR11541A (es) 2010-08-05
CA2710934A1 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
UY30977A1 (es) Derivados de isoindolinas 4' -o-sustituidas. composiciones que las contienen y metodos para sus usos.
UY30314A1 (es) Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
AR062875A1 (es) Compuestos de n- metilaminometil isoindol y composiciones que los comprenden y metodos para utilizarlos
CL2012000033A1 (es) Compuestos n-(3-(4as,7as)-2-amino-4a,5,7,7a-tetrahidro-4h-furo[3,4-d][1,3] tiazin-7a-il)-4- fluorofenilo) -5-fluoropiconilamida, inhibidor de bace; composicion farmaceutica que los comprende, uso del compuesto para el tratamiento de la enfermedad de alzheimer.
DOP2006000193A (es) Compuestos de isoindol-imida y composiciones que los incluye y metodos para su uso
ECSP067062A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
CU23779B7 (es) Compuestos de pirazolina y su uso y composiciones farmacéuticas
AR061272A1 (es) Antagonistas de cgrp
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
ECSP10010317A (es) Derivado 15,16-metilen-17-(1'-propenil)-17-3'-oxidoestra-4-en-3-ona, su uso y medicamento que lo contiene
UY31582A1 (es) Derivado de 17- ( 1' - propenil) - 17-3' - oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen
CR20110045A (es) Derivados de estratrienos que comprenden bioisosteros heterociclicos para el anillo fenëlico a
UY29883A1 (es) Nuevos beta-agonistas que contienen indol, procedimientos para prepararlos, y su empleo como medicamentos
ECSP10010318A (es) Derivado de -lactona del esteroide del ácido 17-hidroxi-19-nor-21-carboxílico, su uso y el medicamento que lo contiene
CU20100138A7 (es) Derivados de 17-(1'-propenil)-17-3'-oxidoestra-4-en-3-ona, su uso y medicamentos que lo contienen
ECSP10010319A (es) Derivado de -lactona de esteroide de ácido 15,16-metilen-17-hidroxi-19-nor-21-carboxílico, su uso y medicamentos que contienen tal derivado
CU20100140A7 (es) Derivados de 15,16-metilen-17-(1'-propenil)-17-3'-oxidoestra-4-en-3-ona, su uso y medicamento que lo contiene
CU20100141A7 (es) Derivados de ganma-lactona del esteroide del ácido 17-hidroxi-19-nor-21-carboxílico, su uso y el medicamento que lo contiene
TH104953A (th) อนุพันธ์ 17-(1'-โพรพีนิล)-17-3'-ออกซิโดเอสตรา-4-อีน-3-โอน, การใช้อนุพันธ์ดังกล่าว และผลิตภัณฑ์ยาที่มีอนุพันธ์
CU20100139A7 (es) Derivados de y-lactona de esteroide de ácido 15,16-metilen-17-hidroxi-19-nor-21-carboxílico, su uso y medicamentos que contienen tal derivado
UY27303A1 (es) Derivados de 4-aminopirimidina
AR095957A2 (es) Un compuesto derivado de piperidinilo, composición farmaceutica que lo comprende y sus usos para la preparación de un medicamento
UY30434A1 (es) Derivados de quinazolina, su preparacion, su uso y medicamentos que los comprenden
DOP2004001045A (es) Derivados de indano heterrociclicos sustituido y compuesto relacionados para el tratamiento de la esquizofrenia

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20171024